Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03826992
Title Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Children's Hospital Medical Center, Cincinnati

acute leukemia

acute lymphoblastic leukemia

acute myeloid leukemia


CPX-351 + Venetoclax

Age Groups: child | adult
Covered Countries USA

Additional content available in CKB BOOST